Experts call it a massive step forward. Dr. Peter Senior from the University of Alberta emphasized the therapy’s potential: “We’ve got a treatment where we’re no longer constrained by organ donors.” Yet widespread use will require immune-safe cell solutions, cost-effective production, and long-term safety data.